Release Details

SOUTH PLAINFIELD, N.J., Jan. 7, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the 33^rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15^th at 11:00 am PT at the Westin St. Francis in San Francisco.

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com. The presentation will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Investor Presentation and R&D Day slides are available at the same website location.

About PTC Therapeutics, Inc.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and in collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-33rd-annual-jp-morgan-healthcare-conference-300017068.html

SOURCE PTC Therapeutics, Inc.